Peritoneal malignancy is a rapidly growing field within surgical oncology. A large body of evidence now exists, but the practical implications of this evidence base remain unclear. This manual provides a practice-oriented guide to the successful set up and running of a peritoneal malignancy unit.
Peritoneal malignancy is a rapidly growing field within surgical oncology. A large body of evidence now exists, but the practical implications of this evidence base remain unclear. This manual provides a practice-oriented guide to the successful set up and running of a peritoneal malignancy unit.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Tom Cecil is Clinical Director at the Peritoneal Malignancy Institute, Basingstoke, Hampshire Hospitals NHS Foundation Trust and Honorary Transplant Surgeon, Oxford University Hospitals, Oxford, UK. John Bunni is a Consultant Colorectal and General Surgeon, Royal United Hospital, Bath, UK. He is also Visiting Lecturer, University of Bath, UK; Honorary Lecturer, Cardiff University, UK and was awarded the ASGBI Gold Medal. Akash Mehta is Consultant Colorectal Surgeon at St Mark's Hospital & Academic Institute, London, UK and holds the ESSO European Certification in Peritoneal Surface Oncology.
Inhaltsangabe
SET: UNDERSTANDING AND ASSESSMENT OF PERITONEAL DISEASE. Appendix tumours and pseudomyxoma peritonei: A 'paradigm' for peritoneal disease. Colorectal peritoneal metastases. Peritoneal mesothelioma. Miscellaneous peritoneal malignancies. Quantitative assessment of peritoneal disease. Imaging in peritoneal malignancy. DIALOGUE: INTRAPERITONEAL CHEMOTHERAPY AND CYTOREDUCTIVE SURGERY. Intraperitoneal chemotherapy. Perioperative and anaesthetic care. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Postoperative care. Postoperative complications. CLOSURE: ONGOING CARE AND FUTURE MANAGEMENT OPTIONS. Histopathological aspects of peritoneal malignancy. Follow-up protocols in peritoneal malignancy. Recurrence of pseudomyxoma peritonei. Future perspectives in peritoneal malignancy.
SET: UNDERSTANDING AND ASSESSMENT OF PERITONEAL DISEASE. Appendix tumours and pseudomyxoma peritonei: A 'paradigm' for peritoneal disease. Colorectal peritoneal metastases. Peritoneal mesothelioma. Miscellaneous peritoneal malignancies. Quantitative assessment of peritoneal disease. Imaging in peritoneal malignancy. DIALOGUE: INTRAPERITONEAL CHEMOTHERAPY AND CYTOREDUCTIVE SURGERY. Intraperitoneal chemotherapy. Perioperative and anaesthetic care. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Postoperative care. Postoperative complications. CLOSURE: ONGOING CARE AND FUTURE MANAGEMENT OPTIONS. Histopathological aspects of peritoneal malignancy. Follow-up protocols in peritoneal malignancy. Recurrence of pseudomyxoma peritonei. Future perspectives in peritoneal malignancy.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826